News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

Regaining $114,000 will bring all short-term holders back into profit, strengthening the bull market narrative; on the other hand, falling below $104,000 could potentially repeat the previous pattern of “post-all-time-high exhaustion.”

Stellar’s growth in users, payments, and real-world adoption, combined with ETF momentum and major upgrades, positions XLM for a strong September outlook.

World Liberty freezes Justin Sun’s WLFI holdings, citing concerns an exchange used user tokens to push down the token’s price.

"The 'Tokenization Parity with Stocks' is a prerequisite for the widespread adoption of stock tokenization, but the larger issue lies on the liquidity side."




- 15:04Over $30 million in liquidations across the entire network in the past hour, mainly long positionsAccording to Jinse Finance, Coinglass data shows that in the past hour, the total liquidation across the network reached $33.87 million, with long positions liquidated for $30.41 million and short positions liquidated for $3.46 million.
- 14:35Peter Schiff: If the Federal Reserve cuts interest rates amid rising inflation, it will be a major policy mistake; BTC not only failed to break out but is showing signs of peaking.ChainCatcher News, economist and cryptocurrency critic Peter Schiff tweeted, "The Federal Reserve may be about to make a major policy mistake—cutting interest rates while inflation is rising. Gold and silver have already broken out to the upside, with mining stocks leading the rally, confirming the trend. However, bitcoin has not broken out and is showing signs of topping out, so investors may need to reassess their portfolio strategies."
- 14:06Bio Protocol: IP tokens will be launched on Bio V2 and sold through Ignition SalesChainCatcher News, Bio Protocol posted on social media stating, "IP tokens will soon be launched on Bio V2 and will be sold through Ignition Sales, targeting BIO and BioXP holders. IPT represents a single atomic unit of science (such as a new compound, screening system, or therapeutic method), which can be generated by BioAgents, BioDAOs, or individual laboratories, and will return value to contributing nodes. Just as AI-driven 'vibe coding' is transforming software engineering, 'vibe science' will soon change drug development as well. The next round of Bio V2 Ignition Sales is planned to take place next week on the Base platform." Risk Warning